USMJ Plans State Of The Art Indoor Marijuana Grow Operation
March 22 2022 - 3:08PM
InvestorsHub NewsWire
Dallas, TX --
March 22, 2022 -- InvestorsHub NewsWire -- North American Cannabis
Holdings, Inc. (USOTC:
USMJ) today announced the company has secured a financing
commitment to construct a state-of-the-art indoor marijuana grow
operation.
USMJ has
recently confirmed its eligibility to apply for the new adult-use
marijuana cultivation license recently passed into law in the State
of New York.
In February,
New York passed a new law to provide provisional marijuana
cultivation licenses to existing hemp
businesses.
USMJ has a subsidiary that has been
growing hemp for CBD for the past four years. The subsidiary
has received an invitation from the New York Office of Cannabis
Management (OCM) to apply for the provisional adult-use cannabis
license.
In preparation
for the license, USMJ has developed plans and secured a financing
commitment to build a state of the art indoor grow
operation.
USMJ is
founded on the core belief that cannabis makes people's lives
better. Cannabis can fight disease, improve wellness and do so in
an environmentally sustainable manner. North American Cannabis
Holdings is dedicated to finding the best possible applications for
cannabis to serve consumers. The Company operates USMJ.com and is
dedicated to Ongoing Cannabis Consumer Product Development that it
can incubate into Future
Spin-offs.
USMJ has one
spin-off and dividend issuance so far in its cannabis incubation
operational history having issued shares of Puration, Inc.
(USOTC:
PURA) in the past. USMJ continues to work closely with
PURA and recently acquired a CBD sports nutrition beverage product
from PURA in a royalty agreement. The EVERx CBD Sports Nutrition
Beverage acquired by USMJ is bottled by Alkame Holdings, Inc.
(USOTC:
ALKM).
Visit the
company’s ecommerce site now and bookmark the site to watch for
more coming announcements and updates:
www.USMJ.com
Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800)
861-1350
Disclaimer/Safe
Harbor: This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that Alkame will achieve significant sales, the failure
to meet schedule or performance requirements of the Company's
contracts, the Company's liquidity position, the Company's ability
to obtain new contracts, the emergence of competitors with greater
financial resources and the impact of competitive pricing. In the
light of these uncertainties, the forward-looking events referred
to in this release might not occur. These statements have not been
evaluated by the Food and Drug Administration. These products are
not intended to diagnose, treat, cure, or prevent any
disease.
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Nov 2024 to Dec 2024
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Dec 2023 to Dec 2024